Merck beats quarterly sales expectations as Keytruda fuels growth
Go back to Merck beats quarterly sales expectations as Keytruda fuels growth| Merck & Co. (NYSE: MRK) | Delayed: 135.75 +0.20 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.55 | 52 Week High | $65.46 | |||
| Open | $134.43 | 52 Week Low | $47.97 | |||
| Day High | $135.97 | P/E | 92.35 | |||
| Day Low | $133.40 | EPS | $1.47 | |||
| Volume | 3,932,875 | |||||

